REZOLUTE, INC. (RZLT) Current Ratio
- Current ratio · latest quarter: Value 9.68×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 9.68× | Current assets / current liabilities. $110.51M ÷ $11.42M ≈ 9.68× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 110.51M USD | Assets, Current |
| Current obligations | 11.42M USD | Liabilities, Current |
| Cash and equivalents | 10.62M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 97.19M USD | Marketable Securities, Current |
| Customer receivables | (m) | |
| Inventory | (m) | Inventory, Net |
| Payables | 5.03M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $110.51M | $11.42M | $10.62M | $97.19M | (m) | (m) | $5.03M | (m) | 9.68× |
| 2026-03-31 | $122.05M | $7.70M | $11.24M | $109.03M | (m) | (m) | $3.19M | (m) | 15.84× |
| 2025-12-31 | $135.11M | $9.53M | $11.94M | $120.99M | (m) | (m) | $3.78M | (m) | 14.18× |
| 2025-09-30 | $154.71M | $10.21M | $9.10M | $143.10M | (m) | (m) | $3.26M | (m) | 15.15× |
| 2025-06-30 | $171.15M | $11.91M | $94.11M | $73.75M | (m) | (m) | $5.81M | (m) | 14.37× |
| 2025-03-31 | $88.73M | $10.53M | $14.60M | $72.30M | (m) | (m) | $6.50M | (m) | 8.43× |
| 2024-12-31 | $98.69M | $10.61M | $8.93M | $87.61M | (m) | (m) | $3.15M | (m) | 9.30× |
| 2024-09-30 | $110.18M | $7.99M | $10.47M | $97.80M | (m) | (m) | $2.18M | (m) | 13.79× |
| 2024-06-30 | $128.65M | $9.61M | $70.40M | $56.48M | (m) | (m) | $4.90M | (m) | 13.39× |
| 2024-03-31 | $82.21M | $6.96M | $5.93M | $74.09M | (m) | (m) | $3.50M | (m) | 11.82× |
| 2023-12-31 | $96.08M | $8.01M | $12.50M | $80.09M | (m) | (m) | $3.59M | (m) | 12.00× |
| 2023-09-30 | $102.64M | $7.20M | $8.06M | $90.67M | (m) | (m) | $2.43M | (m) | 14.27× |
| 2023-06-30 | $104.91M | $5.20M | $16.04M | $85.86M | (m) | (m) | $3.27M | (m) | 20.18× |
| 2023-03-31 | $105.53M | $4.39M | $33.74M | $69.32M | (m) | (m) | $2.95M | (m) | 24.05× |
| 2022-12-31 | $147.61M | $6.31M | $146.75M | (m) | (m) | (m) | $2.84M | (m) | 23.38× |
| 2022-09-30 | $155.63M | $2.43M | $154.32M | (m) | (m) | (m) | $1.11M | (m) | 64.07× |
| 2022-06-30 | $152.10M | $2.46M | $150.41M | (m) | (m) | (m) | $1.13M | (m) | 61.78× |
| 2022-03-31 | $64.33M | $2.88M | $63.42M | (m) | (m) | (m) | $1.56M | (m) | 22.35× |
| 2021-12-31 | $78.10M | $6.45M | $77.40M | (m) | (m) | (m) | $4.35M | (m) | 12.12× |
| 2021-09-30 | $38.34M | $2.60M | $37.29M | (m) | (m) | (m) | $1.59M | (m) | 14.76× |
| 2021-06-30 | $41.99M | $1.97M | $41.05M | (m) | (m) | (m) | $1.03M | (m) | 21.34× |
| 2021-03-31 | $32.20M | $3.59M | $31.99M | (m) | (m) | (m) | $811.00K | (m) | 8.97× |
| 2020-12-31 | $38.15M | $2.73M | $37.60M | (m) | (m) | (m) | $612.00K | (m) | 13.95× |
| 2020-09-30 | $6.89M | $2.92M | $6.40M | (m) | (m) | (m) | $797.00K | (m) | 2.36× |
| 2020-06-30 | $10.52M | $3.23M | $9.96M | (m) | (m) | (m) | $893.00K | (m) | 3.26× |
| 2020-03-31 | $14.17M | $3.53M | $14.03M | (m) | (m) | (m) | $1.26M | (m) | 4.01× |
| 2019-12-31 | $19.97M | $5.54M | $18.18M | (m) | (m) | (m) | $1.25M | (m) | 3.60× |
| 2019-09-30 | $25.92M | $5.52M | $22.10M | (m) | (m) | (m) | $1.32M | (m) | 4.69× |
| 2019-06-30 | $12.14M | $8.38M | $11.57M | (m) | (m) | (m) | $563.00K | (m) | 1.45× |
| 2019-03-31 | $15.36M | $6.62M | (m) | (m) | (m) | (m) | (m) | (m) | 2.32× |
| 2018-12-31 | $422.28K | $2.98M | (m) | (m) | (m) | (m) | (m) | $10.00K | 0.14× |
| 2018-09-30 | $772.99K | $7.34M | (m) | (m) | (m) | (m) | (m) | (m) | 0.11× |
| 2018-06-30 | $2.01M | $6.25M | $1.65M | (m) | (m) | (m) | (m) | (m) | 0.32× |
| 2018-03-31 | $445.93K | $4.37M | (m) | (m) | (m) | (m) | (m) | (m) | 0.10× |
| 2017-12-31 | $1.16M | $2.25M | (m) | (m) | (m) | (m) | (m) | (m) | 0.52× |
| 2017-09-30 | $4.36M | $1.69M | (m) | (m) | (m) | (m) | (m) | (m) | 2.58× |
| 2017-06-30 | $4.93M | $1.77M | (m) | (m) | (m) | (m) | (m) | (m) | 2.78× |
| 2017-03-31 | $4.85M | $2.02M | (m) | (m) | (m) | (m) | (m) | (m) | 2.40× |
| 2016-12-31 | $3.79M | $1.67M | (m) | (m) | (m) | (m) | (m) | (m) | 2.27× |
| 2016-09-30 | $3.73M | $1.49M | (m) | (m) | (m) | (m) | (m) | (m) | 2.51× |
| 2016-06-30 | $4.49M | $1.73M | (m) | (m) | (m) | (m) | (m) | (m) | 2.60× |
| 2016-03-31 | $2.04M | $2.42M | (m) | (m) | (m) | (m) | (m) | (m) | 0.84× |
| 2015-12-31 | $1.84M | $2.49M | (m) | (m) | (m) | (m) | (m) | (m) | 0.74× |
| 2015-09-30 | $3.05M | $1.96M | (m) | (m) | (m) | $186.76K | (m) | (m) | 1.56× |
| 2015-06-30 | $6.12M | $1.71M | (m) | (m) | (m) | (m) | (m) | (m) | 3.59× |
| 2015-03-31 | $8.94M | $1.80M | (m) | (m) | (m) | $92.42K | (m) | (m) | 4.97× |
| 2014-12-31 | $8.73M | $2.37M | (m) | (m) | (m) | $76.14K | (m) | (m) | 3.68× |
| 2014-09-30 | $4.70M | $892.91K | (m) | (m) | (m) | $301.90K | (m) | (m) | 5.26× |
| 2014-06-30 | $6.31M | $964.04K | (m) | (m) | (m) | $289.60K | (m) | (m) | 6.54× |
| 2014-03-31 | $5.98M | $2.86M | (m) | (m) | (m) | $223.00K | $645.70K | (m) | 2.09× |
| 2013-12-31 | $1.86M | $6.54M | (m) | (m) | (m) | $223.00K | $477.50K | (m) | 0.28× |
| 2013-09-30 | $576.03K | $5.68M | (m) | (m) | (m) | $223.00K | $408.88K | (m) | 0.10× |
| 2013-06-30 | $815.55K | $5.27M | (m) | (m) | (m) | $223.00K | $188.35K | (m) | 0.15× |
| 2013-03-31 | $1.28M | $5.12M | (m) | (m) | (m) | $223.00K | $252.44K | (m) | 0.25× |
| 2012-06-30 | $1.07M | $2.36M | (m) | (m) | (m) | $0.00 | $107.02K | (m) | 0.45× |
| 2012-03-31 | $6.94K | $8.85K | (m) | (m) | (m) | (m) | $8.85K | (m) | 0.78× |
| 2011-12-31 | $565.79K | $1.40M | (m) | (m) | (m) | $0.00 | $186.76K | (m) | 0.40× |
| 2011-09-30 | $23.48K | $5.50K | (m) | (m) | (m) | (m) | $5.50K | (m) | 4.27× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |